India Generic Drugs Market Size, Growth, Analysis, Trends, Share, Report 2025-2033

Generic Drugs Market in India 2025:

How Big is the India Generic Drugs Industry?

The India generic drugs market size reached USD 28.06 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 51.47 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033.

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 28.06 Billion

Market Size in 2033: USD 51.47 Billion

Market Growth Rate (CAGR) 2025-2033: 6.97%

India Generic Drugs Market Trends and Drivers:

Indian generic drugs market is growing steadily, driven by a combination of affordability, strong manufacturing base, and growing global and domestic healthcare demand. In essence, generic drugs are cheap alternatives to branded medicines and are an important factor in improving accessibility of healthcare to the vast majority of the country's population, particularly rural and underdeveloped areas. Apart from this, India is also referred to globally as the "pharmacy of the world" for supplying the maximum percentage of generic medicines to developed and developing nations equally, due to its accommodation with global regulatory norms and low-cost manufacturing advantage. Additionally, the increasing number of chronic diseases like diabetes, blood pressure, and cardiovascular diseases has driven long-term medication usage to higher levels, and that is being fulfilled predominantly through the medium of generics. Additionally, initiatives like Jan Aushadhi Scheme from the government and generics in public procurement systems are making more available and accessed at grass roots levels. Furthermore, the increase in healthcare insurance penetration and public health schemes is also enhancing consumption among hospitals and primary healthcare networks.

In addition, patent lapses of several high-value drugs in foreign markets are offering fresh export opportunities for Indian companies. Apart from that, growing local awareness of the efficacy and safety of generic drugs is slowly changing the perception of consumption and faith in unbranded products. In addition to that, a rise in FDA and WHO-GMP approved manufacturing facilities is further solidifying India's position as a global generic drug hub. On top of that, growth in the number of online pharmacies and e-health platforms is facilitating last-mile delivery of generic medicines and competitive pricing guaranteed. Apart from that, consumer frugality and increased out-of-pocket healthcare expenditure are leading even the urban population to switch to generics. On top of that, aggressive promotion by the government of generics prescription by doctors is bringing policy and doctor practice into alignment to favor the market. Apart from this, increased partnerships of Indian pharma firms with global players for bulk sale and contract manufacturing are also driving growth. Overall, there is a synergy of regulatory support, increasing export opportunities, increased public healthcare focus, and economic need for low-cost treatment options that promises India's generic pharma market for long-term and inclusive growth through various segments of healthcare delivery.

Request for a sample copy of this report: https://www.imarcgroup.com/india-generic-drugs-market/requestsample

India Generic Drugs Market Report Segmentation:

The report has segmented the market into the following categories:

Therapy Area Insights:

• Central Nervous System

• Cardiovascular

• Dermatology

• Genitourinary/Hormonal

• Respiratory

• Rheumatology 

• Diabetes

• Oncology

• Others

Drug Delivery Insights:

• Oral

• Injectables

• Dermal/Topical

• Inhalers

Distribution Channel Insights:

• Retail Pharmacies

• Hospital Pharmacies

Regional Insights:

• North India

• South India

• East India

• West India

Top Players Analysis:

The report provides a detailed analysis of the competitive environment. It covers various aspects such as market structure, positioning of key players, top strategies for success, a competitive dashboard, and a company evaluation quadrant. Furthermore, the report includes comprehensive profiles of all major companies. 

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=30695&flag=C

Other Key Points Covered in the Report:

• COVID-19 Impact on the Market

• Porter's Five Forces Analysis

• Strategic Recommendations

• Market Dynamics

• Historical, Current and Future Market Trends

• Market Drivers and Success Factors

• SWOT Analysis

• Value Chain Analysis

• Comprehensive Mapping of the Competitive Landscape

• Top Winning Strategies

• Recent Industry News

• Key Technological Trends & Development

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us: IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-631-791-1145